Multidisciplinary Approach of Immune Checkpoint Inhibitor-Related Pneumonitis: A Key to Address Knowledge and Management Gaps

被引：6

作者：

Perol, Maurice ^{[1
]}

机构：

[1] Leon Berard Canc Ctr, Dept Med Oncol, 28 Promenade Lea & Napoleon Bullukian, F-69908 Lyon, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 08期

关键词：

CELL LUNG-CANCER; TOXICITY;

D O I：

10.1016/j.jtho.2020.05.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1261 / 1264

页数：4

共 25 条

[1] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[2] Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis [J].

Antonia, Scott J. ;

Borghaei, Hossein ;

Ramalingam, Suresh S. ;

Horn, Leora ;

De Castro Carpeno, Javier ;

Pluzanski, Adam ;

Burgio, Marco A. ;

Garassino, Marina ;

Chow, Laura Q. M. ;

Gettinger, Scott ;

Crino, Lucio ;

Planchard, David ;

Butts, Charles ;

Drilon, Alexander ;

Wojcik-Tomaszewska, Joanna ;

Otterson, Gregory A. ;

Agrawal, Shruti ;

Li, Ang ;

Penrod, John R. ;

Brahmer, Julie .

LANCET ONCOLOGY, 2019, 20 (10) :1395-1408

[3] Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis [J].

Baxi, Shrujal ;

Yang, Annie ;

Gennarelli, Renee L. ;

Khan, Niloufer ;

Wang, Ziwei ;

Boyce, Lindsay ;

Korenstein, Deborah .

BMJ-BRITISH MEDICAL JOURNAL, 2018, 360

[4] Characteristics, incidence, and risk factors of immune checkpoint inhibitor related pneumonitis in patients with non-small cell lung cancer [J].

Cho, Jun Yeun ;

Kim, Junghoon ;

Lee, Jong Seok ;

Kim, Yu Jung ;

Kim, Se Hyun ;

Lee, Yeon Joo ;

Cho, Young-Jae ;

Yoon, Ho Il ;

Lee, Jae Ho ;

Lee, Choon-Taek ;

Park, Jong Sun .

LUNG CANCER, 2018, 125 :150-156

[5] Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients [J].

Delaunay, Myriam ;

Cadranel, Jacques ;

Lusque, Amelie ;

Meyer, Nicolas ;

Gounaut, Valerie ;

Moro-Sibilot, Denis ;

Michot, Jean-Marie ;

Raimbourg, Judith ;

Girard, Nicolas ;

Guisier, Florian ;

Planchard, David ;

Metivier, Anne-Cecile ;

Tomasini, Pascale ;

Dansin, Eric ;

Perol, Maurice ;

Campana, Marion ;

Gautschi, Oliver ;

Fruh, Martin ;

Fumet, Jean-David ;

Audigier-Valette, Clarisse ;

Couraud, Sebastien ;

Dalle, Stephane ;

Leccia, Marie-Therese ;

Jaffro, Marion ;

Collot, Samia ;

Prevot, Gregoire ;

Milia, Julie ;

Mazieres, Julien .

EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)

[6] Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors [J].

Fukihara, Jun ;

Sakamoto, Koji ;

Koyama, Junji ;

Ito, Takayasu ;

Iwano, Shingo ;

Morise, Masahiro ;

Ogawa, Masahiro ;

Kondoh, Yasuhiro ;

Kimura, Tomoki ;

Hashimoto, Naozumi ;

Hasegawa, Yoshinori .

CLINICAL LUNG CANCER, 2019, 20 (06) :442-+

[7] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[8] Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study [J].

Garon, Edward B. ;

Hellmann, Matthew D. ;

Rizvi, Naiyer A. ;

Carcereny, Enric ;

Leighl, Natasha B. ;

Ahn, Myung-Ju ;

Eder, Joseph Paul ;

Balmanoukian, Ani S. ;

Aggarwal, Charu ;

Horn, Leora ;

Patnaik, Amita ;

Gubens, Matthew ;

Ramalingam, Suresh S. ;

Felip, Enriqueta ;

Goldman, Jonathan W. ;

Scalzo, Cathie ;

Jensen, Erin ;

Kush, Debra A. ;

Hui, Rina .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) :2518-+

[9]

Liu Q, 2020, AM ASS CANC RES VIRT

[10] The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis [J].

Ma, Ke ;

Lu, Yali ;

Jiang, Shanshan ;

Tang, Jiangong ;

Li, Xin ;

Zhang, Yuyang .

FRONTIERS IN PHARMACOLOGY, 2018, 9

← 1 2 3 →